Reckitt Benckiser to acquire Biofreeze pain relief brand from Performance Health
Reckitt Benckiser Group (RB) has agreed to acquire the Biofreeze topical pain relief brand from Madison Dearborn Partners subsidiary Performance Health for an undisclosed price. ... Read More
Bexson Biomedical raises $4.8m to advance wearable ketamine treatment for pain and mental health disorders
Bexson Biomedical has successfully raised $4.8 million in Series A funding to accelerate the development of its subcutaneous ketamine treatment platform, aimed at revolutionizing pain ... Read More